1-5 of 5
Daniel A. Vallera
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Eradication of Heterogeneous Tumors by T Cells Targeted with Combination Bispecific Chemically Self-assembled Nanorings

Jacob Petersburg, Daniel A. Vallera, Carston R. Wagner
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (3): 371–380.
https://doi.org/10.1158/1535-7163.MCT-22-0515
Published: 02 March 2023
View article titled, Eradication of Heterogeneous Tumors by T Cells Targeted with Combination Bispecific Chemically Self-assembled Nanorings
Open the PDF for Eradication of Heterogeneous Tumors by T Cells Targeted with Combination Bispecific Chemically Self-assembled Nanorings in another window
Includes: Supplementary data
Journal Articles

Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR

Antonella Borgatti, Joseph S. Koopmeiners, Aaron L. Sarver, Amber L. Winter, Kathleen Stuebner, Deborah Todhunter, Anthony E. Rizzardi, Jonathan C. Henriksen, Stephen Schmechel, Colleen L. Forster, Jong-Hyuk Kim, Jerry Froelich, Jillian Walz, Michael S. Henson, Matthew Breen, Kerstin Lindblad-Toh, Felix Oh, Kristy Pilbeam, Jaime F. Modiano, Daniel A. Vallera
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2017) 16 (5): 956–965.
https://doi.org/10.1158/1535-7163.MCT-16-0637
Published: 02 May 2017
View article titled, Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR
Open the PDF for Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR in another window
Includes: Supplementary data
Journal Articles

Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production

Michelle K. Gleason, Michael R. Verneris, Deborah A. Todhunter, Bin Zhang, Valarie McCullar, Sophia X. Zhou, Angela Panoskaltsis-Mortari, Louis M. Weiner, Daniel A. Vallera, Jeffrey S. Miller
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (12): 2674–2684.
https://doi.org/10.1158/1535-7163.MCT-12-0692
Published: 09 December 2012
View article titled, Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production
Open the PDF for Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production in another window
Journal Articles

Targeting Tumor-Initiating Cancer Cells with dCD133KDEL Shows Impressive Tumor Reductions in a Xenotransplant Model of Human Head and Neck Cancer

Nate N. Waldron, Dan S. Kaufman, Seunguk Oh, Zintis Inde, Melinda K. Hexum, John R. Ohlfest, Daniel A. Vallera
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (10): 1829–1838.
https://doi.org/10.1158/1535-7163.MCT-11-0206
Published: 09 October 2011
View article titled, Targeting Tumor-Initiating Cancer Cells with dCD133KDEL Shows Impressive Tumor Reductions in a Xenotransplant Model of Human Head and Neck Cancer
Open the PDF for Targeting Tumor-Initiating Cancer Cells with dCD133KDEL Shows Impressive Tumor Reductions in a Xenotransplant Model of Human Head and Neck Cancer in another window
Journal Articles

Bioengineering a Unique Deimmunized Bispecific Targeted Toxin That Simultaneously Recognizes Human CD22 and CD19 Receptors in a Mouse Model of B-Cell Metastases

Daniel A. Vallera, Seunguk Oh, Hua Chen, Yanqun Shu, Arthur E. Frankel
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (6): 1872–1883.
https://doi.org/10.1158/1535-7163.MCT-10-0203
Published: 09 June 2010
View article titled, Bioengineering a Unique Deimmunized Bispecific Targeted Toxin That Simultaneously Recognizes Human CD22 and CD19 Receptors in a Mouse Model of B-Cell Metastases
Open the PDF for Bioengineering a Unique Deimmunized Bispecific Targeted Toxin That Simultaneously Recognizes Human CD22 and CD19 Receptors in a Mouse Model of B-Cell Metastases in another window